Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $10 billion point-of-care testing market. Chembio's three FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the US: SURE CHECK® HIV 1/2, HIV 1/2 STAT-PAK® and DPP® HIV 1/2 assays. Chembio markets its DPP® HIV-Syphilis assay and other rapid tests internationally to government and donor-funded programs directly and through distributors. Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP®) technology, which has advantages over lateral-flow technologies when it comes to multiplexing and working with challenging matrices. This technology provides Chembio with a significant pipeline of business opportunities for the development and manufacture of new products. Headquartered in Medford, NY, with approximately 150 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U. S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485.
View Top Employees from Chembio Diagnostics, Inc.Website | http://chembio.com/ |
Ticker | CEMI |
Revenue | $34 million |
Funding | $31 million |
Employees | 133 (121 on RocketReach) |
Founded | 1986 |
Address | 555 Wireless Blvd., Hauppauge, New York 11788, US |
Phone | (631) 924-1135 |
Fax | (631) 924-6033 |
Technologies |
JavaScript,
HTML,
PHP
+28 more
(view full list)
|
Industry | Hospital & Health Care, Medical Testing & Clinical Laboratories, Biotechnology, Diagnostic Equipment, Medical Devices, Healthcare, Science and Engineering, Medical Devices & Equipment, Manufacturing, Government, Government and Military, Test & Measurement Equipment, Health Care, Health Diagnostics |
Web Rank | 3 Million |
Keywords | Point Of Care Diagnostics |
Competitors | HemoCue AB, OraSure Technologies, Quidel, TECHLAB, Inc., Trinity Biotech |
SIC | SIC Code 38 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325413 Companies, NAICS Code 32 Companies, NAICS Code 33 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Chembio Diagnostics, Inc. employee's phone or email?
The Chembio Diagnostics, Inc. annual revenue was $34 million in 2024.
Chuck Caso is the General Manager and Chief Commercial Officer of Chembio Diagnostics, Inc..
121 people are employed at Chembio Diagnostics, Inc..
Chembio Diagnostics, Inc. is based in Hauppauge, New York.
The NAICS codes for Chembio Diagnostics, Inc. are [325413, 32, 33, 325, 3254, 32541].
The SIC codes for Chembio Diagnostics, Inc. are [38, 28].